VENROCK ASSOCIATES IV L P Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for VENROCK ASSOCIATES IV L P.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of VENROCK ASSOCIATES IV L P. VENROCK ASSOCIATES IV L P is 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in QUANTENNA COMMUNICATIONS INC ($QTNA) and 10% Owner in Anacor Pharmaceuticals, Inc. ($ANAC) and 10% Owner in Bellerophon Therapeutics, Inc. ($BLPH).
Latest Insider Trading Transactions of VENROCK ASSOCIATES IV L P
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ALIM, ANAC, BLPH, QTNA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28 2019 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Sell | S | 0.44 | 333,010 | 146,091 | 6,435,173 | 6.8 M to 6.4 M (-4.92 %) |
| Oct 28 2019 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Sell | S | 0.45 | 56,242 | 25,511 | 6,768,183 | 6.8 M to 6.8 M (-0.82 %) |
| Oct 28 2019 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Sell | S | 0.50 | 704,595 | 353,354 | 6,824,425 | 7.5 M to 6.8 M (-9.36 %) |
| Oct 28 2019 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Sell | S | 0.44 | 333,010 | 146,091 | 6,435,173 | 6.8 M to 6.4 M (-4.92 %) |
| Oct 28 2019 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Sell | S | 0.45 | 56,242 | 25,511 | 6,768,183 | 6.8 M to 6.8 M (-0.82 %) |
| Oct 28 2019 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Sell | S | 0.50 | 704,595 | 353,354 | 6,824,425 | 7.5 M to 6.8 M (-9.36 %) |
| Mar 14 2019 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.70 | 142,857 | 100,000 | 7,529,020 | 7.4 M to 7.5 M (+1.93 %) |
| Mar 14 2019 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.70 | 142,857 | 100,000 | 7,529,020 | 7.4 M to 7.5 M (+1.93 %) |
| Sep 17 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.18 | 60,000 | 70,944 | 7,386,163 | 7.3 M to 7.4 M (+0.82 %) |
| Sep 17 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.23 | 75,000 | 92,250 | 7,326,163 | 7.3 M to 7.3 M (+1.03 %) |
| Sep 17 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.19 | 75,000 | 89,160 | 7,251,163 | 7.2 M to 7.3 M (+1.05 %) |
| Sep 17 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.18 | 60,000 | 70,944 | 7,386,163 | 7.3 M to 7.4 M (+0.82 %) |
| Sep 17 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.23 | 75,000 | 92,250 | 7,326,163 | 7.3 M to 7.3 M (+1.03 %) |
| Sep 17 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.19 | 75,000 | 89,160 | 7,251,163 | 7.2 M to 7.3 M (+1.05 %) |
| Sep 12 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.15 | 75,000 | 85,913 | 7,176,163 | 7.1 M to 7.2 M (+1.06 %) |
| Sep 12 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.14 | 200,000 | 228,840 | 7,101,163 | 6.9 M to 7.1 M (+2.90 %) |
| Sep 12 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.22 | 200,000 | 243,640 | 6,901,163 | 6.7 M to 6.9 M (+2.98 %) |
| Sep 12 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.15 | 75,000 | 85,913 | 7,176,163 | 7.1 M to 7.2 M (+1.06 %) |
| Sep 12 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.14 | 200,000 | 228,840 | 7,101,163 | 6.9 M to 7.1 M (+2.90 %) |
| Sep 12 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 1.22 | 200,000 | 243,640 | 6,901,163 | 6.7 M to 6.9 M (+2.98 %) |
| Sep 07 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.90 | 60,000 | 53,742 | 6,701,163 | 6.6 M to 6.7 M (+0.90 %) |
| Sep 07 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.84 | 50,000 | 42,095 | 6,641,163 | 6.6 M to 6.6 M (+0.76 %) |
| Sep 07 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.85 | 50,000 | 42,325 | 6,591,163 | 6.5 M to 6.6 M (+0.76 %) |
| Sep 07 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.90 | 60,000 | 53,742 | 6,701,163 | 6.6 M to 6.7 M (+0.90 %) |
| Sep 07 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.84 | 50,000 | 42,095 | 6,641,163 | 6.6 M to 6.6 M (+0.76 %) |
| Sep 07 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.85 | 50,000 | 42,325 | 6,591,163 | 6.5 M to 6.6 M (+0.76 %) |
| Aug 16 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.65 | 66,393 | 43,109 | 6,541,163 | 6.5 M to 6.5 M (+1.03 %) |
| Aug 16 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.65 | 272,000 | 175,902 | 6,474,770 | 6.2 M to 6.5 M (+4.39 %) |
| Aug 16 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.65 | 190,977 | 123,868 | 6,202,770 | 6 M to 6.2 M (+3.18 %) |
| Aug 16 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.65 | 66,393 | 43,109 | 6,541,163 | 6.5 M to 6.5 M (+1.03 %) |
| Aug 16 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.65 | 272,000 | 175,902 | 6,474,770 | 6.2 M to 6.5 M (+4.39 %) |
| Aug 16 2018 | BLPH | Bellerophon Therap ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 0.65 | 190,977 | 123,868 | 6,202,770 | 6 M to 6.2 M (+3.18 %) |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 60,551 | 0 | 0 | |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 383,634 | 0 | 0 | |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 469,779 | 0 | 0 | |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 805,625 | 0 | 0 | |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 94,321 | 0 | 0 | |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 71,744 | 0 | 0 | |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 322,411 | 0 | 0 | |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 60,551 | 0 | 2,653,269 | 2.6 M to 2.7 M (+2.34 %) |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 383,634 | 0 | 2,592,718 | 2.2 M to 2.6 M (+17.37 %) |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 469,779 | 0 | 2,209,084 | 1.7 M to 2.2 M (+27.01 %) |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 805,625 | 0 | 1,739,305 | 933.7 K to 1.7 M (+86.28 %) |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 186,644 | 0 | 933,680 | 747 K to 933.7 K (+24.98 %) |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 138,696 | 0 | 747,036 | 608.3 K to 747 K (+22.80 %) |
| Nov 04 2016 | QTNA | QUANTENNA COMMUNIC ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 608,340 | 0 | 608,340 | 0 to 608.3 K |
| Mar 17 2014 | AKAO | Achaogen Inc | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 382,913 | 0 | 0 | |
| Mar 17 2014 | AKAO | Achaogen Inc | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 725,873 | 0 | 0 | |
| Mar 17 2014 | AKAO | Achaogen Inc | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 223,440 | 0 | 0 | |
| Mar 17 2014 | AKAO | Achaogen Inc | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 296,981 | 0 | 0 | |
| Mar 17 2014 | AKAO | Achaogen Inc | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 382,913 | 0 | 1,746,461 | 1.4 M to 1.7 M (+28.08 %) |
| Mar 17 2014 | AKAO | Achaogen Inc | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 725,873 | 0 | 1,363,548 | 637.7 K to 1.4 M (+113.83 %) |
| Mar 17 2014 | AKAO | Achaogen Inc | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 296,878 | 0 | 637,675 | 340.8 K to 637.7 K (+87.11 %) |
| Mar 17 2014 | AKAO | Achaogen Inc | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 340,797 | 0 | 340,797 | 0 to 340.8 K |
| May 10 2011 | ALIM | ALIMERA SCIENCES I ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | J | 0.00 | 11,293 | 0 | 3,110,363 | 3.1 M to 3.1 M (+0.36 %) |
| May 10 2011 | ALIM | ALIMERA SCIENCES I ... | VENROCK ASSOCIATES IV L P | 10% Owner | Sell | J | 0.00 | 850,000 | 0 | 3,099,070 | 3.9 M to 3.1 M (-21.52 %) |
| Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 139,105 | 0 | 0 | |
| Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 133,622 | 0 | 0 | |
| Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 1,752,808 | 0 | 0 | |
| Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 5.00 | 600,000 | 3,000,000 | 2,625,535 | 2 M to 2.6 M (+29.62 %) |
| Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 139,105 | 0 | 2,025,535 | 1.9 M to 2 M (+7.37 %) |
| Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 133,622 | 0 | 1,886,430 | 1.8 M to 1.9 M (+7.62 %) |
| Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 1,752,808 | 0 | 1,752,808 | 0 to 1.8 M |
| Apr 28 2010 | ALIM | ALIMERA SCIENCES I ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 465,157 | 0 | 0 | |
| Apr 28 2010 | ALIM | ALIMERA SCIENCES I ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 934,110 | 0 | 0 | |
| Apr 28 2010 | ALIM | ALIMERA SCIENCES I ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 2,243,732 | 0 | 0 | |
| Apr 28 2010 | ALIM | ALIMERA SCIENCES I ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 11.00 | 306,071 | 3,366,781 | 3,949,070 | 3.6 M to 3.9 M (+8.40 %) |
| Apr 28 2010 | ALIM | ALIMERA SCIENCES I ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 465,157 | 0 | 3,642,999 | 3.2 M to 3.6 M (+14.64 %) |
| Apr 28 2010 | ALIM | ALIMERA SCIENCES I ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 934,110 | 0 | 3,177,842 | 2.2 M to 3.2 M (+41.63 %) |
| Apr 28 2010 | ALIM | ALIMERA SCIENCES I ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 2,243,732 | 0 | 2,243,732 | 0 to 2.2 M |
Page: 1